Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment (Q80025874)
Jump to navigation
Jump to search
scientific article published on 01 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment |
scientific article published on 01 August 2006 |
Statements
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group (English)
Sylvie Giacchetti
Carlo Garufi
Dominique Genet
Stefano Iacobelli
Marco Tampellini
Christian Focan
Yves Humblet
Jean Luc Canon
Antoine Adenis
Carlos Carvalho
Johannes Schueller
Nicole Anciaux
Marie-Ange Lentz
Benoît Baron
Thierry Gorlia
Francis Lévi
European Organisation for Research and Treatment of Cancer Chronotherapy Group
1 August 2006